RIPK1 and systemic inflammatory response syndrome: recently identified Zharp-99, an unclassified small molecule kinase inhibitor of RIPK3, which blocked necroptosis in human and mouse cells without inducing RIPK1-dependent apoptosis and also blocked TNF-induced SIRS in mice (140).